新浦安内科・脳神経内科クリニック | 浦安市 内科 脳神経内科 | パーキンソン病 生活習慣病 高血圧 脂質異常 糖尿病

新浦安内科・脳神経内科クリニック 浦安市 内科 脳神経内科

京葉線「新浦安駅」駅より徒歩2分

新浦安内科・脳神経内科クリニック 浦安市 内科 脳神経内科 はインターネット予約が可能です

新浦安内科・脳神経内科クリニック 浦安市 内科 脳神経内科 の電話番号047-381-0077

業績

  • 58. Hatano T, Kano O, Sengoku R, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Yanagisawa N, Nagayama H. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study. BMC Neurol. 2022 Mar 3;22(1):71.
  • 57. Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Fukae J, Nakamura R, Kurita N, Tsunemi T, Oji Y, Saiki S, Nishioka K, Takeshige-Amano H, Taniguchi D, Ogawa T, Kamo H, Eguchi H, Fuse A, Nakajima A, Kano M, Nakajima S, Yanagisawa N, Hattori N. Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD). BMJ Open 2022 Feb 11;12(2):e054129.
  • 56. Shimizu M, Ogaki K, Nakamura R, Kado E, Nakajima S, Kurita N, Watanabe M, Yamashiro K, Hattori N, Urabe T.. An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination. eNeurologicalSci. 2021 Dec;25:100381.
  • 55. The East Asian Parkinson Disease Genomics Consortium. Mok KY; East Asian Parkinson Disease Genomics Consortium. Lancet Neurol. 2021 Dec;20(12):982.
  • 54. Shimada T, Nakajima S, Nakamura R, Kurita N, Ogaki K, Watanabe M, Yamashiro K, Urabe T. Hashimoto's encephalopathy with gait disturbance caused by sensory ganglionopathy: A case report and review of the literature. eNeurologicalSci. 2021 Oct 2;25:100370.
  • 53. Balint B, Ogawa T, Ogaki K, Daida K, Nishimaki T, Ando M, Kawajiri S, Wada R, Noda K, Hattori N, Okuma Y, Barsottini O. Commentary: Progressive Encephalomyelitis with Rigidity and Myoclonus and Myasthenia Gravis Comorbid Status with Thymoma. Mov Disord Clin Pract. 2021 Sep 3;8(Suppl 1):S14-S15.
  • 52. Ogawa T, Ogaki K, Daida K, Nishimaki T, Ando M, Kawajiri S, Wada R, Noda K, Hattori N, Okuma Y. Progressive Encephalomyelitis with Rigidity and Myoclonus and Myasthenia Gravis Comorbid Status with Thymoma. Mov Disord Clin Pract. 2021 Sep 3;8(Suppl 1):S11-S13.
  • 51. Ogawa T, Ogaki K, Mori Y, Kamo H, Uchiyama A, Kamagata K, Nagaoka M, Hattori N. Neuronuclear and Neuromelanin-Sensitive Imaging for Acquired Hepatocerebral Degeneration with Parkinsonism. Mov Disord Clin Pract. 2021 Mar 26;8(3):464-468.
  • 50. Yasaka K, Kamagata K, Ogawa T, Hatano T, Takeshige-Amano H, Ogaki K, Andica C, Akai H, Kunimatsu A, Uchida W, Hattori N, Aoki S, Abe O. Parkinson's disease: deep learning with a parameter-weighted structural connectome matrix for diagnosis and neural circuit disorder investigation. Neuroradiology. 2021 Sep;63(9):1451-1462.
  • 49. Kamiya K, Kamagata K, Ogaki K, Hatano T, Ogawa T, Takeshige-Amano H, Murata S, Andica C, Murata K, Feiweier T, Hori M, Hattori N, Aoki S. Brain White-Matter Degeneration Due to Aging and Parkinson Disease as Revealed by Double Diffusion Encoding. Front Neurosci. 2020 Oct 15;14:584510.
  • 48. Daida K, Funayama M, Li Y, Yoshino H, Hayashida A, Ikeda A, Ogaki K, Nishioka K, Hattori N. Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease. Front Neurol. 2020 Sep 29;11:576465.
  • 47. Ogawa T, Ogaki K, Ishiguro M, Ando M, Yoshida T, Noda K, Hattori N, Okuma Y. Novel GFAP p. Glu206Ala Mutation in Alexander Disease with Decreased Dopamine Transporter Uptake. Mov Disord Clin Pract. 2020 Jul 6;7(6):720-722.
  • 46. Hayashida A, Li Y, Yoshino H, Daida K, Ikeda A, Ogaki K, Fuse A, Mori A, Takanashi M, Nakahara T, Yoritaka A, Tomizawa Y, Furukawa Y, Kanai K, Nakayama Y, Ito H, Ogino M, Hattori Y, Hattori T, Ichinose Y, Takiyama Y, Saito T, Kimura T, Aizawa H, Shoji H, Mizuno Y, Matsushita T, Sato M, Sekijima Y, Morita M, Iwasaki A, Kusaka H, Tada M, Tanaka F, Sakiyama Y, Fujimoto T, Nagara Y, Kashihara K, Todo H, Nakao K, Tsuruta K, Yoshikawa M, Hara H, Yokote H, Murase N, Nakamagoe K, Tamaoka A, Takamiya M, Morimoto N, Nokura K, Kako T, Funayama M, Nishioka K, Hattori N. The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1. Neurobiol Aging. 2021 Jan;97:146.e1-146.e13.
  • 45. Noda K, Ando M, Jo T, Hattori A, Ogaki K, Sugiyama M, Hattori N, Okuma Y. Mesial Frontal Lobe Infarction Presenting as Pisa Syndrome. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104882.
  • 44. Li Y, Ikeda A, Yoshino H, Oyama G, Kitani M, Daida K, Hayashida A, Ogaki K, Yoshida K, Kimura T, Nakayama Y, Ito H, Sugeno N, Aoki M, Miyajima H, Kimura K, Ueda N, Watanabe M, Urabe T, Takanashi M, Funayama M, Nishioka K, Hattori N Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan. J Hum Genet. 2020 Sep;65(9):771-781.
  • 43. Yamashita Y, Ogawa T, Ogaki K, Kamo H, Sukigara T, Kitahara E, Izawa N, Iwamuro H, Oyama G, Kamagata K, Hatano T, Umemura A, Kosaki R, Kubota M, Shimo Y, Hattori N. Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report. J Neurol Sci. 2020 Apr 15;411:116710.
  • 42. Kamagata K, Andica C, Hatano T, Ogawa T, Takeshige-Amano H, Ogaki K, Akashi T, Hagiwara A, Fujita S, Aoki S. Advanced diffusion magnetic resonance imaging in patients with Alzheimer’s and Parkinson’s diseases. Neural Regen Res. 2020 Sep;15(9):1590-1600
  • 41. Andica C, Kamagata K, Hatano T, Saito Y, Ogaki K, Hattori N, Aoki S. MR biomarkers of degenerative brain disorders derived from diffusion imaging. J Magn Reson Imaging. 2020 Dec;52(6):1620-1636.
  • 40. Daida K, Ogaki K, Hayashida A, Ando M, Yokoyama K, Noda K, Kanbayashi T, Hattori N, Okuma Y. Somnolence Preceded the Development of a Subthalamic Lesion in Neuromyelitis Optica Spectrum Disorder: A Case Report. Intern Med. 2020 Feb 15;59(4):577-579.
  • 39. Shimada T, Tsunemi T, Hattori A, Nakazato-Taniguchi T, Yasuhara H, Ogaki K, Hattori N.Bilateral thigh compartment syndromes from extended sitting with forward bending. J Clin Neurosci. 2019 Jun;64:35-37.
  • 38. Mezaki N, Miura T, Ogaki K, Eriguchi M, Mizuno Y, Komatsu K, Yamazaki H, Suetsugi N, Kawajiri S, Yamasaki R, Ishiguro T, Konno T, Nozaki H, Kasuga K, Okuma Y, Kira JI, Hara H, Onodera O, Ikeuchi T. Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy. Neurol Genet. 2018 Dec 7;4(6):e292.
  • 37. Ogaki K, Heckman MG, Koga S, Martens YA, Labbé C, Lorenzo-Betancor O, Walton RL, Soto AI, Vargas ER, Fujioka S, Uitti RJ, van Gerpen JA, Cheshire WP, Younkin SG, Wszolek ZK, Low PA, Singer W, Bu G, Dickson DW, Ross OA. Association study between multiple system atrophy and TREM2 p.R47H. Neurol Genet. 2018 Aug 1;4(4):e257.
  • 36. Ogaki K, Martens YA, Heckman MG, Koga S, Labbé C, Lorenzo-Betancor O, Wernick AI, Walton RL, Soto AI, Vargas ER, Nielsen HM, Fujioka S, Kanekiyo T, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Low PA, Singer W, Dickson DW, Bu G, Ross OA. Multiple system atrophy and apolipoprotein E. Mov Disord. 2018 Apr;33(4):647-650.
  • 35. Ando M, Fiesel FC, Hudec R, Caulfield TR, Ogaki K, Górka-Skoczylas P, Koziorowski D, Friedman A, Chen L, Dawson VL, Dawson TM, Bu G, Ross OA, Wszolek ZK, Springer W. The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity. Mol Neurodegener. 2017 Apr 24;12(1):32.
  • 34. Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzinska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W. Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. Brain. 2017 Jun 1;140(6):e33.
  • 33. Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W.Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism. Brain. 2017 Jan;140:98-117.
  • 32. Walton RL, Soto-Ortolaza AI, Murray ME, Lorenzo-Betancor O, Ogaki K, Heckman MG, Rayaprolu S, Rademakers R, Ertekin-Taner N, Uitti RJ, van Gerpen JA, Wszolek ZK, Smith GE, Kantarci K, Lowe VJ, Parisi JE, Jones DT, Savica R, Graff-Radford J, Knopman DS, Petersen RC, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA, Labbé C. TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurol Genet. 2016 Jul 14;2(4):e85
  • 31. Labbé C, Heckman MG, Lorenzo-Betancor O, Murray ME, Ogaki K, Soto-Ortolaza AI, Walton RL, Fujioka S, Koga S, Uitti RJ, van Gerpen JA, Petersen RC, Graff-Radford NR, Younkin SG, Boeve BF, Cheshire WP Jr, Low PA, Sandroni P, Coon EA, Singer W, Wszolek ZK, Dickson DW, Ross OA. MAPT haplotype diversity in multiple system atrophy. Parkinsonism Relat Disord. 2016 Sep;30:40-5.
  • 30. Koga S, Josephs KA, Ogaki K, Labbé C, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Aoki N, Rademakers R, Wszolek ZK, Ross OA, Dickson DW. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C. Mov Disord. 2016 May;31(5):653-62..
  • 29. Ogaki K, Koga S, Heckman MG, Fiesel FC, Ando M, Labbé C, Lorenzo-Betancor O, Moussaud-Lamodière EL, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Puschmann A, Nishioka K, Funayama M, Hattori N, Parisi JE, Petersen RC, Graff-Radford NR, Boeve BF, Springer W, Wszolek ZK, Dickson DW, Ross OA. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders. Neurology. 2015 Dec 8;85(23):2016-25.
  • 28. Wren MC, Zhao J, Liu CC, Murray ME, Atagi Y, Davis MD, Fu Y, Okano HJ, Ogaki K, Strongosky AJ, Tacik P, Rademakers R, Ross OA, Dickson DW, Wszolek ZK, Kanekiyo T, Bu G. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells. Mol Neurodegener. 2015 Sep 15;10(1):46.
  • 27. Labbé C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, Puschmann A, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Sanotsky Y, Rektorová I, McLean PJ, Rademakers R, Ertekin-Taner N, Hassan A, Ahlskog JE, Boeve BF, Petersen RC, Maraganore DM, Adler CH, Ferman TJ, Parisi JE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies. Neurology. 2015 Nov 10;85(19):1680-6.
  • 26. Lorenzo-Betancor O, Ogaki K, Soto-Ortolaza AI, Labbe C, Walton RL, Strongosky AJ, van Gerpen JA, Uitti RJ, McLean PJ, Springer W, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, McCarthy A, Lynch T, Puschmann A, Rektorova I, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Ferman TJ, Boeve BF, Petersen RC, Parisi JE, Graff-Radford NR, Dickson DW, Wszolek ZK, Ross OA. DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients. Eur J Neurol. 2015 Sep;22(9):1323-5.
  • 25. Ogaki K, Koga S, Aoki N, Lin W, Suzuki K, Ross OA, Dickson DW. Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review. Neuropathology. 2015 Feb;36(1):64-76.
  • 24. Labbé C, Ogaki K, Lorenzo-Betancor O, Carrasquillo MM, Heckman MG, McCarthy A, Soto-Ortolaza AI, Walton RL, Lynch T, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Dickson DW, Uitti RJ, Wszolek ZK, Ross OA. Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson's Disease Locus. PLoS One.10:e0128586,2015
  • 23. Fiesel FC, Caulfield TR, Moussaud-Lamodière EL, Ogaki K, Dourado DF, Flores SC, Ross OA, Springer W. Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.Hum Mutat. 2015 Aug;36(8):774-86.
  • 22. Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, Li Y, Ogaki K, Ando M, Yoshino H, Tomiyama H, Nishioka K, Hasegawa K, Saiki H, Satake W, Mogushi K, Sasaki R, Kokubo Y, Kuzuhara S, Toda T, Mizuno Y, Uchiyama Y, Ohno K, Hattori N. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015 Mar;14(3):274-82.
  • 21. Fujioka S, Sanchez Contreras MY, Strongosky AJ, Ogaki K, Whaley NR, Tacik PM, van Gerpen JA, Uitti RJ, Ross OA, Wszolek ZK, Rademakers R, Dickson DW. Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. Parkinsonism Relat Disord. 2015 Feb;21(2):101-5.
  • 20. Heckman MG, Schottlaender L, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Ogaki K, Fujioka S, Murray ME, Cheshire WP, Uitti RJ, Wszolek ZK, Farrer MJ, Sailer A, Singleton AB, Chinnery PF, Keogh MJ, Gentleman SM, Holton JL, Aoife K, Mann DM, Al-Sarraj S, Troakes C, Dickson DW, Houlden H, Ross OA. LRRK2 exonic variants and risk of multiple system atrophy. Neurology. 2014 Dec 9;83(24):2256-61.
  • 19. Lorenzo-Betancor O, Ogaki K, Soto-Ortolaza A, Labbé C, Vilariño-Güell C, Rajput A, Rajput AH, Pastor P, Ortega S, Lorenzo E, Strongosky AJ, van Gerpen JA, Uitti RJ, Wszolek ZK, Ross OA. Analysis of nuclear export sequence regions of FUS-Related RNA-binding proteins in essential tremor. PLoS One. 2014 Nov 6;9(11):e111989.
  • 18. Ogaki K, Fujioka S, Heckman MG, Rayaprolu S, Soto-Ortolaza AI, Labbé C, Walton RL, Lorenzo-Betancor O, Wang X, Asmann Y, Rademakers R, Graff-Radford N, Uitti R, Cheshire WP, Wszolek ZK, Dickson DW, Ross OA. Analysis of COQ2 gene in multiple system atrophy. Mol Neurodegener. 2014 Nov 5;9:44.
  • 17. Aoki N, Murray ME, Ogaki K, Fujioka S, Rutherford NJ, Rademakers R, Ross OA, Dickson DW. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol. 2015 Jan;129(1):53-64.
  • 16. Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium. Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology. 2014 Nov 18;83(21):1906-13.
  • 15. Ogaki K, Ross OA. Chromosome 22q11.2 deletion may contain a locus for recessive early-onset Parkinson's disease. Parkinsonism Relat Disord. 2014 Sep;20(9):945-6.
  • 14. Nishioka K, Funayama M, Vilariño-Güell C, Ogaki K, Li Y, Sasaki R, Kokubo Y, Kuzuhara S, Kachergus JM, Cobb SA, Takahashi H, Mizuno Y, Farrer MJ, Ross OA, Hattori N. EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. Parkinsonism Relat Disord. 2014 Jun;20(6):659-61.
  • 13. Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK. Update on novel familial forms of Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1(0 1):S29-34.
  • 12. Labbé C, Rayaprolu S, Soto-Ortolaza A, Ogaki K, Uitti RJ, Wszolek ZK, Ross OA. Investigating FUS variation in Parkinson's disease. Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1(0 1):S147-9.
  • 11. Nakamura R, Atsuta N, Watanabe H, Hirakawa A, Watanabe H, Ito M, Senda J, Katsuno M, Tanaka F, Izumi Y, Morita M, Ogaki K, Taniguchi A, Aiba I, Mizoguchi K, Okamoto K, Hasegawa K, Aoki M, Kawata A, Abe K, Oda M, Konagaya M, Imai T, Nakagawa M, Tsuji S, Kaji R, Nakano I, Sobue G. Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1365-71.
  • 10. Ogaki K, Li Y, Takanashi M, Ishikawa K, Kobayashi T, Nonaka T, Hasegawa M, Kishi M, Yoshino H, Funayama M, Tsukamoto T, Shioya K, Yokochi M, Imai H, Sasaki R, Kokubo Y, Kuzuhara S, Motoi Y, Tomiyama H, Hattori N. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord. 2013 Jan;19(1):15-20.
  • 9. Ando M, Funayama M, Li Y, Kashihara K, Murakami Y, Ishizu N, Toyoda C, Noguchi K, Hashimoto T, Nakano N, Sasaki R, Kokubo Y, Kuzuhara S, Ogaki K, Yamashita C, Yoshino H, Hatano T, Tomiyama H, Hattori N. VPS35 mutation in Japanese patients with typical Parkinson's disease. Mov Disord. 2012 Sep 15;27(11):1413-7.
  • 8. Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, Watanabe H, Nakamura R, Yoshino H, Yato S, Tamura A, Naito Y, Taniguchi A, Fujita K, Izumi Y, Kaji R, Hattori N, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS). Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Neurobiol Aging. 2012 Oct;33(10):2527.e11-6.
  • 7. Ogaki K, Hirayama T, Chijiiwa K, Fukae J, Furuya T, Noda K, Fujishima K, Hattori N, Takahashi T, Okuma Y. Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis. Neurologist. 2012 Mar;18(2):76-9
  • 6. Ogaki K, Motoi Y, Li Y, Tomiyama H, Shimizu N, Takanashi M, Nakanishi A, Yokoyama K, Hattori N. Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): a comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy. Mov Disord. 2011 Feb 15;26(3):561-3.
  • 5. Tomiyama H, Yoshino H, Ogaki K, Li L, Yamashita C, Li Y, Funayama M, Sasaki R, Kokubo Y, Kuzuhara S, Hattori N. PLA2G6 variant in Parkinson's disease. J Hum Genet. 2011 May;56(5):401-3.
  • 4. Funayama M, Tomiyama H, Wu RM, Ogaki K, Yoshino H, Mizuno Y, Hattori N. Rapid screening of ATP13A2 variant with high-resolution melting analysis. Mov Disord. 2010 Oct 30;25(14):2434-7.
  • 3. Yoshino H, Tomiyama H, Tachibana N, Ogaki K, Li Y, Funayama M, Hashimoto T, Takashima S, Hattori N. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology.12;75:1356-61,2010.
  • 2. Ogaki K, Fukae J, Noda K, Fujishima K, Hattori N, Okuma Y. Blurred vision with acute hypertension indicating hypertensive brainstem encephalopathy-case report-. Neurol Med Chir (Tokyo). 2009 Dec;49(12):625-30.
  • 1. Kamigaichi R, Kubo S, Ishikawa K, Yokoyama K, Ogaki K, Usui C, Hatta K, Arai H, Mochizuki H,Hattori N. Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report. Eur J Neurol.16:e6,2009.

和文

  • 12. 大垣光太郎, 服部信孝, プレシジョンメディスンの現状と展望, シンポジウム5: Parkinson 病の新規薬物療法:最新の動向と展望, 神経治療 38:330–335,2021
  • 11. 大垣光太郎, 服部信孝, 遺伝性パーキンソン病の研究から目指す治療法開発 「順天堂脳神経内科ではこうしている ---最新・パーキンソン病診療」 (日本医事新報), 東京 p.69-73, 2021
  • 10. 大垣光太郎, 服部信孝, 遅発性ジスキネジア[私の治療], 週刊日本医事新報 (日本医事新報), 東京 p.32, 2020
  • 9. 大垣光太郎, 服部信孝: パーキンソン病. 希少疾病ライブラリ CareNet.com, 株式会社ケアネット (東京都), http://www.carenet.com/report/library/general/rare/pd.html, 2019
  • 8. 大垣光太郎, 新規PD/parkinsonism遺伝子(劣性および伴性遺伝性など): 22q11.2del,SYNJ1,RAB39B,DNAJC6,PODXL,PTRHD1), 日本臨牀/増刊 パーキンソン病(第2版), 日本臨床社, 東京. 2018
  • 7. 大垣光太郎, 西岡健弥, 服部信孝. パーキンソン病の遺伝子研究, 遺伝子医学MOOK別冊 シリーズ:最新遺伝医学研究と遺伝カウンセリング シリーズ2「最新精神・神経遺伝医学研究と遺伝カウンセリング」, 三木義男 編, メディカルドゥ, 東京, p125-131, 2017
  • 6. 大垣光太郎, 富山弘幸. 日本のALSにおけるC9orf72遺伝子解析と現在までのC9orf72研究, 難病と在宅ケア20:19-22, 2014
  • 5. 大垣光太郎, 大熊泰之. 歩行障害 責任病巣はどこか. ジェネラル診療シリーズ すべての内科医が知っておきたい 神経疾患の診かた、考え方とその対応. 大生定義 編,羊土社,東京,pp77-81,2013.
  • 4. 大垣光太郎:コレ・シカール症候群 症候群ハンドブック,中山書店,pp40,2011
  • 3. 島田佳明,上野祐司,久保紳一郎,大垣光太郎,田中亮太,宮元伸和,田中康貴,卜部貴夫,服部信孝.中大脳動脈閉塞をきたした薬物中毒患者.分子脳血管病9:130-131,2010
  • 2. 大垣光太郎,野田和幸,深江治郎ら.アムホテリシンBリポソーム製剤およびボリコナゾールが奏功した高齢発症のクリプトコッカス髄膜炎の1例.Brain Nerve 62:1337-1340,2010.
  • 1. 井田正博, 吉廣昭子, 大垣光太郎, 長尾毅彦. MR拡散画像と造影灌流画像 脳虚血超急性期の血栓溶解療法を前提として. 臨床画像 22(suppl-1): 52-67 2006

受賞

  • 2005年度 都立病院ジュニアレジデント合同発表会 優秀賞
  • 2013年 公益財団法人 内藤記念科学振興財団 海外研究留学助成金
  • 2013年 ノバルティス老化および老年医学研究基金・海外研究交流助成
  • 2015年 順天堂大学脳神経内科同窓会 水野賞
  • 2019年 生体アミンと神経疾患に関する研究助成

共同研究・競争的資金等の研究課題

  • パーキンソン病はリソソーム病か?大規模臨床的・遺伝学的アプローチ
    公的研究費 科研費 若手研究 2019年4月 - 2022年3月
    大垣光太郎
  • 「パーキンソン病のマクロ神経回路異常の解明:先端的MRIと人工知能による統合解析」 (研究分担者)
    公的研究費 AMED 戦略的国際脳科学研究推進プログラム 2018年11月 - 2021年3月
    鎌形康司
  • 「次世代シーケンサーによるparkinの新規modifier 遺伝子同定と機能解明 」
    公的研究費 科研費 若手研究(B) 2017年4月 - 2019年4月
    大垣光太郎
  • 「多系統萎縮症のリスク遺伝子研究」
    順天堂大学大学院医学研究科 環境医学研究所 順天堂大学環境医学研究所プロジェクト研究 2016年4月 - 2018年3月
    大垣光太郎
  • 「次世代シークエンサーによる大脳皮質基底核変性症の新規原因遺伝子探索」
    公的研究費 科研費 研究活動スタート支援 2015年8月 - 2017年3月
    大垣光太郎
症状から探す
物忘れ
頭痛
めまい
力が入らない
ふるえ
しびれ
ろれつが回らない
病名から探す
生活習慣病
パーキンソン病
脳梗塞・脳卒中
認知症
てんかん
重症筋無力症
筋萎縮性側索硬化症(ALS)
多発性硬化症
脊髄小脳変性症
眼瞼けいれん
顔面けいれん

問診票ダウンロード

このページの先頭へ戻る